Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NASDAQInformation TechnologySoftware - InfrastructureSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
8.47 → 8.47 EPS · FY ending Dec 31, 2027 · 14 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 14 to 14; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for QLYS yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
EPS meets or exceeds $5.5 for FY26 | A primary condition in Qualys's published investment case. The stated target is >=5.5 USD per share. | Broken | EPS guidance falls below $5.3 for FY26 | Diluted EPS: $1.50 per share FY2026-Q2; GAAP. Published target: >=5.5 USD per share. Annual target cannot be compared with a quarterly or TTM observation. Aug 4, 20261.5 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a profitable growth business with a steady record of revenue increases and improving operating income. The long-term thesis is intact, but confidence has eased from high to medium and the risk assessment is high.
The valuation is tagged as stretched, while the evidence also describes it as cheap versus peers. The model shows a 66% premium versus peers and an expectations gap of 18%, so the market appears to expect continued execution despite the mixed valuation signals.
Over the multi-year view, recent results support continued growth: revenue has risen about 10% to 11% year over year, and operating income, net income, and EPS have also increased. Near term, the miss risk is assessed as low, but recent misses among industry peers and a deep miss in QLYS’s history remain relevant; a guidance cut after the recent increase would also damage credibility.
The central company-specific swing factor is whether management sustains growth and profitability gains without reversing its recently raised guidance. Near-term sector conditions may also matter: Fed rate cuts or stabilization among major technology companies could ease pressure on the sector, while continued weakness could weigh on the setup.
For the next 1 to 3 years, QLYS has a sound operating record and an intact long-term thesis, balanced against high risk and stretched expectations. The view depends on continued execution and avoiding a guidance reversal. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in Qualys's published investment case. The stated target is >=50.6M USD. |
| Intact |
| Net income falls below $48M in FY26-Q1 |
Net income: $52.405M FY2026-Q2; GAAP. Published target: >=50.6M USD. Target period is not explicitly aligned with this observation. Aug 4, 202652,405,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of 3 supplied quarters. Management reported: “Net Income: GAAP net income for the second quarter of 2026 increased by 11% to $52.4 million, or $1.50 per diluted share, compared to $47.3 million, or $1.29 per diluted share, for the same quarter in 2025.” “GAAP net income per diluted share is now expected to be in the range of $5.76 to $5.90, up from the previous guidance range of $5.40 to $5.61.” Net income was $52.405 million in 2026-Q2. Delivery assessment Nov 2, 2026 |
Operating income increases to at least $60.9M | Profit margins improve with operating income rising from $51.8M to $60.9M in one year. | Broken | Operating income falls below $55M in FY26-Q1 | Operating income: $61.902M FY2026-Q2; GAAP. Published target: >=60.9M USD. Target period is not explicitly aligned with this observation. Aug 4, 202661,902,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of 3 supplied quarters. Management reported: “Operating Income: GAAP operating income for the second quarter of 2026 increased by 20% to $61.9 million compared to $51.4 million for the same quarter in 2025.” “As a percentage of revenues, GAAP operating income was 34% for the second quarter of 2026 compared to 31% for the same quarter in 2025.” Operating income was $61.902 million in 2026-Q2. Delivery assessment Nov 2, 2026 |
Revenue grows at least 8.8% YoY | A primary condition in Qualys's published investment case. The stated target is >=8.8% YoY. | Broken | YoY revenue growth falls below 7% in FY26 | Revenue: $182.175M FY2026-Q2; GAAP. Published target: >=8.8% YoY. Annual target cannot be compared with a quarterly or TTM observation. Aug 4, 2026182,175,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of 3 supplied quarters. Management reported: “Second Quarter 2026 Financial Highlights Revenues: Revenues for the second quarter of 2026 increased by 11% to $182.2 million compared to $164.1 million for the same quarter in 2025.” “Full Year 2026 Guidance: Management now expects revenues for the full year of 2026 to be in the range of $732.0 million to $738.0 million, representing 9% to 10% growth over 2025.” Revenue was $182.175 million in 2026-Q2. Delivery assessment Nov 2, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$8.27 → $8.47 · observed estimates
$0.78B → $0.80B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $8.27 | $775,711,200 | 22 / 22 |
| 2026-07-25 | $8.27 | $775,711,200 | 22 / 22 |
| 2026-07-26 | $8.27 | $775,711,200 | 22 / 22 |
| 2026-07-27 | $8.27 | $775,711,200 | 22 / 22 |
| 2026-07-28 | $8.27 | $775,711,200 | 22 / 22 |
| 2026-07-29 | $8.27 | $775,711,200 | 22 / 22 |
| 2026-07-30 | $8.31 | $775,259,010 | 14 / 17 |
| 2026-07-31 | $8.27 | $775,711,200 | 22 / 22 |
| 2026-08-01 | $8.31 | $775,259,010 | 14 / 17 |
| 2026-08-02 | $8.27 | $775,711,200 | 22 / 22 |
| 2026-08-03 | $8.27 | $775,711,200 | 22 / 22 |
| 2026-08-04 | $8.27 | $775,711,200 | 22 / 22 |
| 2026-08-05 | $8.31 | $775,259,060 | 14 / 17 |
| 2026-08-06 | $8.31 | $775,259,060 | 14 / 17 |
| 2026-08-07 | $8.45 | $794,088,197 | 14 / 16 |
| 2026-08-08 | $8.42 | $793,700,850 | 22 / 22 |
| 2026-08-09 | $8.42 | $793,700,850 | 22 / 22 |
| 2026-08-10 | $8.42 | $793,700,850 | 22 / 22 |
| 2026-08-12 | $8.45 | $794,088,197 | 14 / 16 |
| 2026-08-13 | $8.45 | $794,088,197 | 14 / 16 |
| 2026-08-14 | $8.45 | $794,088,197 | 14 / 16 |
| 2026-08-15 | $8.45 | $794,088,197 | 14 / 16 |
| 2026-08-16 | $8.45 | $794,088,197 | 14 / 16 |
| 2026-08-17 | $8.45 | $794,088,197 | 14 / 16 |
| 2026-08-18 | $8.45 | $794,088,197 | 14 / 16 |
| 2026-08-19 | $8.45 | $794,088,197 | 14 / 16 |
| 2026-08-20 | $8.47 | $795,990,137 | 14 / 17 |
| 2026-08-21 | $8.47 | $795,990,137 | 14 / 17 |
| 2026-08-22 | $8.47 | $795,990,137 | 14 / 17 |
| 2026-08-23 | $8.47 | $795,990,137 | 14 / 17 |
| 2026-08-24 | $8.47 | $795,990,137 | 14 / 17 |
| 2026-08-25 | $8.47 | $795,990,137 | 14 / 17 |
| 2026-08-26 | $8.47 | $795,990,137 | 14 / 17 |
| 2026-08-27 | $8.47 | $795,990,137 | 14 / 17 |
| 2026-08-28 | $8.47 | $795,990,137 | 14 / 17 |
| 2026-08-29 | $8.47 | $795,992,108 | 14 / 17 |
| 2026-08-30 | $8.47 | $795,992,108 | 14 / 17 |
| 2026-08-31 | $8.47 | $795,992,108 | 14 / 17 |
| 2026-09-01 | $8.47 | $795,992,108 | 14 / 17 |
| 2026-09-02 | $8.47 | $795,992,108 | 14 / 17 |
| 2026-09-03 | $8.47 | $795,992,108 | 14 / 17 |
| 2026-09-04 | $8.47 | $795,992,108 | 14 / 17 |
| 2026-09-05 | $8.47 | $795,992,108 | 14 / 17 |
| 2026-09-06 | $8.47 | $795,992,108 | 14 / 17 |
| 2026-09-07 | $8.47 | $795,992,108 | 14 / 17 |
| 2026-09-08 | $8.47 | $795,992,108 | 14 / 17 |
| 2026-09-09 | $8.47 | $795,992,108 | 14 / 17 |
| 2026-09-10 | $8.47 | $795,992,108 | 14 / 17 |
| 2026-09-11 | $8.47 | $795,992,503 | 14 / 17 |
| 2026-09-12 | $8.47 | $795,992,503 | 14 / 17 |
| 2026-09-13 | $8.47 | $795,992,503 | 14 / 16 |
| 2026-09-14 | $8.47 | $795,992,503 | 14 / 16 |
| 2026-09-15 | $8.47 | $795,992,503 | 14 / 16 |
| 2026-09-16 | $8.47 | $795,992,505 | 14 / 17 |
| 2026-09-17 | $8.47 | $795,992,505 | 14 / 17 |
| 2026-09-18 | $8.47 | $795,992,505 | 14 / 17 |
| 2026-09-19 | $8.47 | $795,992,505 | 14 / 17 |
| 2026-09-20 | $8.47 | $795,992,505 | 14 / 17 |
| 2026-09-21 | $8.47 | $795,992,505 | 14 / 17 |
| 2026-09-22 | $8.47 | $795,992,505 | 14 / 17 |
| 2026-09-23 | $8.47 | $795,992,505 | 14 / 17 |
| 2026-09-24 | $8.47 | $795,992,505 | 14 / 17 |
| 2026-09-25 | $8.47 | $795,992,505 | 14 / 17 |
| 2026-09-26 | $8.47 | $795,992,505 | 14 / 17 |
| 2026-09-27 | $8.47 | $795,992,505 | 14 / 17 |
| 2026-09-28 | $8.47 | $795,992,505 | 14 / 17 |
| 2026-09-29 | $8.47 | $795,992,505 | 14 / 17 |
| 2026-09-30 | $8.47 | $795,992,505 | 14 / 17 |
| 2026-10-01 | $8.47 | $795,992,505 | 14 / 17 |
| 2026-10-02 | $8.47 | $795,970,070 | 14 / 17 |
| 2026-10-03 | $8.47 | $795,970,070 | 14 / 17 |
| 2026-10-04 | $8.47 | $795,970,070 | 14 / 17 |
| 2026-10-05 | $8.47 | $795,970,070 | 14 / 17 |
| 2026-10-06 | $8.47 | $795,970,070 | 14 / 17 |
| 2026-10-07 | $8.47 | $795,992,503 | 14 / 17 |
| 2026-10-08 | $8.47 | $795,992,503 | 14 / 17 |
| 2026-10-09 | $8.47 | $795,992,503 | 14 / 17 |
| 2026-10-10 | $8.47 | $795,992,503 | 14 / 17 |
| 2026-10-11 | $8.47 | $795,992,503 | 14 / 17 |
| 2026-10-12 | $8.47 | $795,992,503 | 14 / 17 |
| 2026-10-13 | $8.47 | $795,992,503 | 14 / 17 |
| 2026-10-14 | $8.47 | $795,972,503 | 14 / 17 |
| 2026-10-15 | $8.47 | $795,972,503 | 14 / 17 |
| 2026-10-16 | $8.47 | $795,974,871 | 14 / 17 |
| 2026-10-17 | $8.47 | $795,974,871 | 14 / 17 |
| 2026-10-18 | $8.47 | $795,974,871 | 14 / 17 |
| 2026-10-19 | $8.47 | $795,974,871 | 14 / 17 |
| 2026-10-20 | $8.47 | $795,974,871 | 14 / 17 |
| 2026-10-21 | $8.47 | $795,974,871 | 14 / 17 |
| 2026-10-22 | $8.47 | $795,974,871 | 14 / 17 |
| 2026-10-23 | $8.47 | $795,974,871 | 14 / 17 |
| 2026-10-24 | $8.47 | $795,974,871 | 14 / 17 |
| 2026-10-25 | $8.47 | $795,974,871 | 14 / 17 |
| 2026-10-26 | $8.47 | $795,974,871 | 14 / 17 |
| 2026-10-27 | $8.47 | $795,974,871 | 14 / 17 |
| 2026-10-28 | $8.47 | $795,992,503 | 14 / 17 |
| 2026-10-29 | $8.47 | $795,992,503 | 14 / 17 |
| 2026-10-30 | $8.47 | $795,994,393 | 14 / 17 |
| 2026-10-31 | $8.47 | $795,994,393 | 14 / 17 |
| 2026-11-01 | $8.47 | $795,994,393 | 14 / 17 |
| 2026-11-02 | $8.47 | $795,994,393 | 14 / 17 |
| 2026-11-03 | $8.47 | $795,994,393 | 14 / 17 |
| 2026-11-04 | $8.47 | $795,994,393 | 14 / 17 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 4 Buy / Strong Buy · 16 Hold · 2 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 1 recorded
1 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.